tetano
Editor, Senior Moderator
Cochrane Database Syst Rev
. 2026 May 18:5:CD016350.
doi: 10.1002/14651858.CD016350.
Interventions for treating COVID-19 in people with chronic kidney disease
Samar Abd ElHafeez[SUP] 1 [/SUP], Patrizia Natale[SUP] 2 3 [/SUP], Kimia Hosseini[SUP] 3 [/SUP], Marta Colaneri[SUP] 4 5 6 [/SUP], Maurizio Gallieni[SUP] 5 [/SUP], Giovanni Fm Strippoli[SUP] 2 3 [/SUP]; supported by Cochrane Kidney and Transplant Review Group
Affiliations
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of interventions for treating coronavirus disease 2019 (COVID-19) in people with all chronic kidney disease (CKD) stages, including those undergoing dialysis and kidney transplant recipients.
. 2026 May 18:5:CD016350.
doi: 10.1002/14651858.CD016350.
Interventions for treating COVID-19 in people with chronic kidney disease
Samar Abd ElHafeez[SUP] 1 [/SUP], Patrizia Natale[SUP] 2 3 [/SUP], Kimia Hosseini[SUP] 3 [/SUP], Marta Colaneri[SUP] 4 5 6 [/SUP], Maurizio Gallieni[SUP] 5 [/SUP], Giovanni Fm Strippoli[SUP] 2 3 [/SUP]; supported by Cochrane Kidney and Transplant Review Group
Affiliations
- PMID: 42145268
- DOI: 10.1002/14651858.CD016350
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of interventions for treating coronavirus disease 2019 (COVID-19) in people with all chronic kidney disease (CKD) stages, including those undergoing dialysis and kidney transplant recipients.